compounded tirzepatide sublingual suspension (13mg) 1 and GIP therapy Struggling to feel full? Compounded

Symptoms such as unexplained central weight gain, persistent fatigue, muscle weakness, easy bruising, wide purple striae, or severe hypotension warrant cortisol evaluation before attributing these to metabolic syndrome alone

Nausea, diarrhea, and vomiting are the most common adverse events, particularly during dose escalation

Our analysis showed the gastrointestinal AEs signal with strong clinical priority was pancreatitis with score 8

Tirzepatide's triggering of GIP increases insulin release and may have cardiovascular benefits by changing the way lipids are used

Had the product for a couple of weeks now Very happy with this product Easy to use and as advertised

Phase 3 results from the ATTAIN trials show meaningful weight loss